Recall
Active
FDA
Official source
Direct Rx: DULOXETINE D/R, a) 30 mg ( Recall
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Product details: DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC...
- Company
- Direct Rx
- Deadline
- No deadline listed
- Source
- U.S. Food and Drug Administration